VivoSim Labs, Inc. (VIVS)
NASDAQ: VIVS · Real-Time Price · USD
1.970
+0.075 (3.96%)
Jul 10, 2025, 4:00 PM - Market closed
VivoSim Labs Market Cap
VivoSim Labs has a market cap or net worth of $5.12 million as of July 11, 2025. Its market cap has decreased by -55.07% in one year.
Market Cap
5.12M
Enterprise Value
-5.25M
1-Year Change
-55.07%
Ranking
Category
Stock Price
$1.97
Market Cap Chart
Since February 14, 2012, VivoSim Labs's market cap has decreased from $11.20M to $5.12M, a decrease of -54.27%. That is a compound annual growth rate of -5.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 5.10M | -28.17% |
| Dec 31, 2024 | 7.10M | -27.55% |
| Dec 29, 2023 | 9.80M | -20.33% |
| Dec 30, 2022 | 12.30M | -61.08% |
| Dec 31, 2021 | 31.60M | -61.84% |
| Dec 31, 2020 | 82.80M | 78.45% |
| Dec 31, 2019 | 46.40M | -58.16% |
| Dec 31, 2018 | 110.90M | -22.61% |
| Dec 29, 2017 | 143.30M | -59.30% |
| Dec 30, 2016 | 352.10M | 53.02% |
| Dec 31, 2015 | 230.10M | -60.58% |
| Dec 31, 2014 | 583.70M | -31.77% |
| Dec 31, 2013 | 855.50M | 600.66% |
| Dec 31, 2012 | 122.10M | 990.18% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.72B |
| Johnson & Johnson | 379.12B |
| AbbVie | 345.72B |
| Novo Nordisk | 308.58B |
| UnitedHealth Group | 273.46B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 232.55B |
| AstraZeneca | 223.49B |